Trial Profile
Efficacy of zoledronic acid in patients with bone metastases from differenciated thyroid carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2016
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone metastases
- Focus Therapeutic Use
- 29 Sep 2016 New trial record
- 01 Dec 2011 Recruitment completed according to results published in the Annals of Surgical Oncology.